Navigation Links
Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Release of Study Finding Tylenol Use in Pregnancy May Affect Child Development
Date:12/19/2013

st 100 Tylenol lawsuits involving liver damage allegations are now pending in a federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. All of the lawsuits allege that Tylenol products can cause liver damage, even when taken as directed. The lawsuits further allege that many victims of Tylenol liver damage were hospitalized, required a liver transplant, or died, as a result of acetaminophen in the over-the-counter medications. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

This past summer, Johnson & Johnson announced it was adding more prominent, red-lettered warnings to the labels of Tylenol products regarding the potential for sever liver damage. According to a report from Bloomberg.com, Extra Strength Tylenol – which contains 500 milligrams of acetaminophen per tablet - was to appear with the warnings in October. Other products will bear the warnings in the coming months.**

Individuals who suffered acetaminophen-induced liver damage resulting in hospitalization, liver transplantation or death allegedly associated with a Tylenol product may be entitled to compensation for medical expenses and other injury-related damages. Find out more about filing a Tylenol lawsuit by visiting Bernstein Liebhard LLP’s website. For a free evaluation of your claim, please call 800-511-5092.

*ije.oxfordjournals.org/content/early/2013/10/24/ije.dyt183.abstract, Journal of Epidemiology, October 2013
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, incl
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Tylenol Liver Problem Allegations Help: Resource4thePeople Comments on Legal Developments
2. Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Tylenol Litigation
3. Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Claim Alleging Use of Tylenol Caused Liver Damage
4. Tylenol Liver Damage Allegations Lawyer Help: Resource4thePeople Reports Judge Outlines Procedures for Bellwether Trials
5. Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
6. Tylenol Lawsuit News: New Jersey Supreme Court Refuses Multicounty Case Consolidation, Rottenstein Law Group LLP Reports
7. Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople Urges Consumers to Fully Inform Themselves about Liver Disease Danger Possibility
8. Rottenstein Law Group LLP Announces New Tylenol Lawsuit Center
9. Update on Alleged Tylenol Liver Failure Lawsuits from Resource4thePeople: Judge Selects Steering Committee in Multidistrict Litigation
10. Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center
11. Anxious about life? Tylenol may do the trick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Zaca Life ... the go. With no water needed, the refreshing berry-flavored tablets are the perfect ... get the natural ingredients that may help with body detoxification, protection and hydration,” ...
(Date:7/30/2015)... Los Angeles, CA (PRWEB) , ... July 30, 2015 , ... ... driverless cars on an upcoming dedicated web site. As discussed in a June 8, ... of the minor collisions reported so far have been caused by its computer-driven cars, ...
(Date:7/30/2015)... CA (PRWEB) , ... July ... ... recently released a video, “Beachside Nursing Center,” to announce its position as ... five-star ratings. Beachside's administrator and staff members support the CMS rating system, ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is a ... That Increases Training Capability , World renown body weight trainer, Paul Ziachik, ... ), that dramatically increases a person’s training capability. , The American College of ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web Marketing ... Summit. Google Partners is the platform for search marketing agencies to communicate with ... tools necessary to run successful search marketing campaigns. Google Partners also affords businesses ...
Breaking Medicine News(10 mins):Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2
... (Nasdaq: KNDL ) announced today that it ... the market closes on Wednesday, May 6, 2009. The ... webcast on Thursday, May 7 at 8:30 a.m. Eastern ... http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO ) Conference ...
... Pharmacy benefit manager Prime Therapeutics (Prime) announced today its ... Heart Walk. Prime is participating both as a sponsor ... 11 Blue Cross and Blue Shield Plans. Prime provides ... a deep commitment to improving the health of members," ...
... in 2017 for the Treatment of STEMI with ... from Decision ResourcesWALTHAM, Mass., April 23 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... mortality as the attribute that most influences their ...
... Expansion with Plans to Triple Overall Lab Capacity; Builds ... PLUS Diagnostics, a leading anatomic pathology company, announced today ... opening of a West Coast laboratory in Orange County, ... into a new laboratory in Union, New Jersey to ...
... InfoLogix, Inc. (Nasdaq: ... of enterprise mobility solutions for the healthcare and ... into an agreement with Gwinnett Medical Center ... suburban Atlanta, to deploy a next-generation, handheld Care ...
... ,high-glycemic, carbs, researchers say , , THURSDAY, April 23 (HealthDay News) ... workout may influence how many calories you burn during your ... rich in carbohydrates that do not cause a spike in ... burned 50 percent more fat during a post-breakfast workout than ...
Cached Medicine News:Health News:Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast 2Health News:For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro 2Health News:For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro 3Health News:PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services 2Health News:PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services 3Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 2Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 3Health News:A Pre-Workout Meal to Help You Burn Fat 2Health News:A Pre-Workout Meal to Help You Burn Fat 3
(Date:7/30/2015)... PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... second quarter ending June 30, 2015. ... We are excited to be near the completion of ... with topline results expected in the fourth quarter," stated ... Inc. "Translarna is now commercially available in 12 countries ...
(Date:7/30/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... regarding the notice it received on May 21, 2015 ... the Company was below certain of the Exchange,s continued ... 1101 of the NYSE MKT Company Guide, due to ...
(Date:7/30/2015)... 2015 Eisai Inc. announced today that regulatory ... States , European Union and Japan ... for eribulin, for the treatment of patients with inoperable ... for advanced or metastatic disease. These ... global Phase 3 clinical trial (Study 309), which met ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... Cepheid (NASDAQ: CPHD) ... Officer, received the Ernst & Young Entrepreneur Of The ... category. According to Ernst & Young LLP, the award ... in such areas as innovation, financial performance and personal ...
... 28, 2011 Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: ... Russell 3000®, Russell 2000® and Russell Global Indexes posted by ...   Annual reconstitution of Russell,s U.S. indexes captures ... May, ranking them by total market capitalization. Membership in the ...
Cached Medicine Technology:Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner 2Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner 3Cell Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 2Cell Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 3
Eye Bank Specular Microscope. Specular microscope for easy examination of corneal slice extracted from a donor....
... system uses prolene as thread-guide reducing time and ... Probe is inserted into the nasolacrimal duct and ... The probe is then withdrawn leaving the polypropylene ... diam silicone tubing into place. Newly coated with ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... conforms to natural anatomy of the ... on disposable inserter/dilator instrument for ease ... The Micro-Large plugs feature the unique ... shape of the eyelid. The slightly ...
Medicine Products: